🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as melphalan, leucovorin, oxali...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
2004-12
Trial ID
NCT00103298
Treatments Being Tested
Randomized, open label, multicentre phase II trial followed by phase III co...
Status
Completed
Location
CRLC Val d'Aurelle
Start Date
2004-04
Trial ID
NCT00208260
Treatments Being Tested
This study is to investigate the efficacy and safety of Folfox4 chemotherap...
Status
Unknown
Location
Multiple Locations
Start Date
2016-10
Trial ID
NCT02813096
Treatments Being Tested
The purpose of this study is to determine efficacy of NKCell combined FOLFO...
Status
Unknown
Location
The catholic University of korea
Start Date
2009-01
Trial ID
NCT00854854
Treatments Being Tested
In this study, the investigators assessed the effect of Cetuximab in combin...
Status
Unknown
Location
Zhongshan Hospital, Fudan University
Start Date
2006-09
Trial ID
NCT01564810
Treatments Being Tested
This is an open label, randomized, controlled, multicenter phase II study c...
Status
Completed
Location
Research Site
Start Date
2005-07
Trial ID
NCT00125034
Treatments Being Tested
The investigators propose to conduct an observational study on consecutive ...
Status
Unknown
Location
M. Skłodowska-Curie National Research Institute of Oncology
Start Date
2021-08-03
Trial ID
NCT05241574
Treatments Being Tested
The purpose of this study is to analyze the clinical tolerance of immediate...
Status
Terminated
Location
Institut Gustave Roussy
Start Date
2012-07
Trial ID
NCT01715363
Treatments Being Tested
FOLFOX4 plus Avastin has been suggested as firstline regimen for advanced c...
Status
Unknown
Location
The Affiliated Changzhou Tumor Hospital of Suzhou University
Start Date
2008-10
Trial ID
NCT00813137
Treatments Being Tested
This study aims to assess the efficacy of durvalumab in combination with ra...
Status
Completed
Location
Centre Oscar Lambret, CLCC UNICANCER
Start Date
2018-12-05
Trial ID
NCT03777813
Treatments Being Tested